clinical trials for tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention Tirzepatide: First Approval | Drugs

If you stop the medication, having a healthy lifestyle in place can help you maintain your new weight and body shape

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide Eli Lilly and Company announced results today from the SURPASS-CVOT trial, a head-to-head cardiovascular outcomes trial comparing two tirzepatide (Mounjaro) with dulaglutide (Trulicity) in adults with type 2 diabetes and established atherosclerotic cardiovascular disease

Crackers, toast, white rice, bananas, applesauce, plain chicken breast, baked potatoes, and clear broths tend to sit well

The role of the vagal nerve in peripheral PYY 3-36-induced feeding reduction in rats

I would eat six donuts, or a whole bag of candy